Cargando…

“No-Reflow” Phenomenon: A Contemporary Review

Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for patients with STEMI according to current international guidelines of the European Society of Cardiology. Coronary no-reflow is characterized by angiographic evidence of slow or no anterograde epicardial flow,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Annibali, Gianmarco, Scrocca, Innocenzo, Aranzulla, Tiziana Claudia, Meliga, Emanuele, Maiellaro, Francesco, Musumeci, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028464/ https://www.ncbi.nlm.nih.gov/pubmed/35456326 http://dx.doi.org/10.3390/jcm11082233

Ejemplares similares

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2022)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

The No-reflow Phenomenon: Is it Predictable by Demographic factors and Routine Laboratory Data?
por: Namazi, Mohammadhasan, et al.
Publicado: (2021)

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

Intravascular Ultrasound Observation of the Mechanism of No-Reflow Phenomenon in Acute Myocardial Infarction
por: Li, Junxia, et al.
Publicado: (2015)

Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act
por: Musumeci, Giuseppe, et al.
Publicado: (2023)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study
por: Jafari Afshar, Elmira, et al.
Publicado: (2023)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
por: Song, Nian-Peng, et al.
Publicado: (2020)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
por: Grancini, Luca, et al.
Publicado: (2023)

Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
por: Wang, Lan, et al.
Publicado: (2015)

Matryoshka procedure for Valve‐in‐Valve TAVI failure
por: Lodo, Vittoria, et al.
Publicado: (2022)

No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction()
por: Katayama, Yosuke, et al.
Publicado: (2022)

No-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical Implications
por: Ahn, Seong Joon, et al.
Publicado: (2015)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis
por: Fajar, Jonny Karunia, et al.
Publicado: (2018)

Delayed Treatment With Hypothermia Protects Against the No‐Reflow Phenomenon Despite Failure to Reduce Infarct Size
por: Hale, Sharon L., et al.
Publicado: (2013)

Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon
por: Qin, Tao, et al.
Publicado: (2013)

Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention
por: Abdi, Seifollah, et al.
Publicado: (2015)

hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention
por: Liu, Min, et al.
Publicado: (2017)

The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction
por: Bolayır, Hasan Ata, et al.
Publicado: (2017)

Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts
por: Hashemi-Jazi, Mohammad, et al.
Publicado: (2017)

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient
por: Buono, Andrea, et al.
Publicado: (2019)

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD
por: Hosoda, Hayato, et al.
Publicado: (2023)

No-reflow phenomenon during percutaneous coronary intervention in a patient with polycythemia vera: A case report
por: Oktaviono, Yudi Her, et al.
Publicado: (2020)

Another step in transcatheter aortic valve implantation: A challenging transcatheter aortic valve implantation procedure in patient with severe peripheral arterial disease
por: Lodo, Vittoria, et al.
Publicado: (2022)

Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
por: Shemirani, Hassan, et al.
Publicado: (2014)

Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study
por: Darwish, Ahmed, et al.
Publicado: (2022)

Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction
por: Kożuch, Marcin, et al.
Publicado: (2022)

Pseudo-no-Reflow Phenomenon in Carotid Artery Stenting using FilterWire EX: Successful Recovery by Aspiration Thrombectomy
por: Han, Seung Hwan, et al.
Publicado: (2009)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention
por: Liu, Fang, et al.
Publicado: (2021)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2022)

The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis
por: Savic, Lidija, et al.
Publicado: (2022)

Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention
por: Wang, Le, et al.
Publicado: (2016)

Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Cheng, Chao, et al.
Publicado: (2019)

Assessment of No-Reflow Phenomenon by Myocardial Blush Grade and Pulsed Wave Tissue Doppler Imaging in Patients with Acute Coronary Syndrome
por: Novo, Giuseppina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h62q95m67ekdh63igomo1nhin7